Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-01

Clinical Trial Update: Risk Factors for Postpartum Hemorrhage

View source ↗

Summary

A completed RenJi Hospital clinical trial studied risk factors for postpartum hemorrhage, including systemic autoimmune diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: RenJi Hospital | Conditions: Postpartum Hemorrhage, Systemic Autoimmune Diseases | Status: COMPLETED